A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma

<div>TIC profiles in LUAD samples and association assay. (a) Visualisation of the infiltration levels of several immunocytes in the LUAD specimens and nontumor samples. (b) The association among all immune cells.</div>

Journal of Immunology Research

fig4

Figure 4

Figure 4: A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma 